Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-17
DOI
10.3389/fcimb.2021.684515
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- It's Time to Reverse our Thinking: The Reverse Translation Research Paradigm
- (2018) Valentina Shakhnovich CTS-Clinical and Translational Science
- Antibiotic–non-antibiotic combinations for combating extremely drug-resistant Gram-negative ‘superbugs’
- (2017) Elena K. Schneider et al. Essays in Biochemistry
- The antibiotic pipeline: reviving research and development and speeding drugs to market
- (2017) Katherine H. Luepke et al. Expert Review of Anti-Infective Therapy
- The FDA’s Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016
- (2017) Thomas J. Hwang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps
- (2017) Victoria L Simpkin et al. JOURNAL OF ANTIBIOTICS
- The antibiotic resistance crisis, with a focus on the United States
- (2017) Evan Martens et al. JOURNAL OF ANTIBIOTICS
- Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus
- (2017) Saskia Zimmermann et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Opportunities and challenges in phenotypic drug discovery: an industry perspective
- (2017) John G. Moffat et al. NATURE REVIEWS DRUG DISCOVERY
- Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study
- (2017) Sana R Mostaghim et al. BMJ-British Medical Journal
- Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study
- (2017) Sana R Mostaghim et al. BMJ-British Medical Journal
- Teixobactin and Its Analogues: A New Hope in Antibiotic Discovery
- (2017) William D. Fiers et al. ACS Infectious Diseases
- Antibiotic Resistance: A Public Health Crisis
- (2017) Boris D. Lushniak PUBLIC HEALTH REPORTS
- Regulatory Incentives for Antibiotic Drug Development: A Review of Recent Proposals
- (2016) Michael S. Sinha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Accelerating the discovery of antibacterial compounds using pathway-directed whole cell screening
- (2016) Leigh M. Matano et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations From the Transatlantic Task Force on Antimicrobial Resistance: Table 1.
- (2016) Kimberly Sciarretta et al. CLINICAL INFECTIOUS DISEASES
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- Natural product discovery: past, present, and future
- (2016) Leonard Katz et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology Drugs
- (2016) Chul Kim et al. MAYO CLINIC PROCEEDINGS
- Antibacterial drug discovery in the resistance era
- (2016) Eric D. Brown et al. NATURE
- Parsing clinical success rates
- (2016) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications
- (2016) Katherine H. Luepke et al. PHARMACOTHERAPY
- Natural Products as a Source for Novel Antibiotics
- (2016) Mark G. Moloney TRENDS IN PHARMACOLOGICAL SCIENCES
- Endless resistance. Endless antibiotics?
- (2016) Jed F. Fisher et al. MedChemComm
- A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility
- (2016) David M. Brogan et al. Globalization and Health
- A Target-Based Whole Cell Screen Approach To Identify Potential Inhibitors of Mycobacterium tuberculosis Signal Peptidase
- (2016) Shilah A. Bonnett et al. ACS Infectious Diseases
- Unconventional screening approaches for antibiotic discovery
- (2015) Maya A. Farha et al. Annals of the New York Academy of Sciences
- Repurposing metformin: an old drug with new tricks in its binding pockets
- (2015) R. Pryor et al. BIOCHEMICAL JOURNAL
- Thalidomide-induced teratogenesis: History and mechanisms
- (2015) Neil Vargesson BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
- Antibacterial Drug Discovery: Doing It Right
- (2015) Martin Gengenbacher et al. CHEMISTRY & BIOLOGY
- Drug Repurposing for the Treatment of Staphylococcal Infections
- (2015) Shankar Thangamani et al. CURRENT PHARMACEUTICAL DESIGN
- Drug repositioning and repurposing: terminology and definitions in literature
- (2015) Joris Langedijk et al. DRUG DISCOVERY TODAY
- The resurgence of phenotypic screening in drug discovery and development
- (2015) Bridget K. Wagner Expert Opinion on Drug Discovery
- A new antibiotic kills pathogens without detectable resistance
- (2015) Losee L. Ling et al. NATURE
- ESKAPEing the labyrinth of antibacterial discovery
- (2015) Ruben Tommasi et al. NATURE REVIEWS DRUG DISCOVERY
- Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
- (2015) David Brown NATURE REVIEWS DRUG DISCOVERY
- The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development
- (2015) Emma Heslop et al. Orphanet Journal of Rare Diseases
- Incentives to Repurpose Existing Drugs for Orphan Indications
- (2015) Annette K. Kwok et al. ACS Medicinal Chemistry Letters
- The FDA’s new clothes
- (2015) Donald W Light et al. BMJ-British Medical Journal
- Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study
- (2015) Aaron S Kesselheim et al. BMJ-British Medical Journal
- The FDA’s new clothes
- (2015) Donald W Light et al. BMJ-British Medical Journal
- Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study
- (2015) Aaron S Kesselheim et al. BMJ-British Medical Journal
- FDA Designations for Therapeutics and Their Impact on Drug Development and Regulatory Review Outcomes
- (2015) AS Kesselheim et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Assessments of Thioridazine as a Helper Compound to Dicloxacillin against Methicillin-Resistant Staphylococcus aureus: In Vivo Trials in a Mouse Peritonitis Model
- (2015) Michael Stenger et al. PLoS One
- Something old, something new: revisiting natural products in antibiotic drug discovery
- (2014) Gerard D. Wright CANADIAN JOURNAL OF MICROBIOLOGY
- Antibiotic Adjuvants: Diverse Strategies for Controlling Drug-Resistant Pathogens
- (2014) Erin E. Gill et al. Chemical Biology & Drug Design
- Update on the antibiotic resistance crisis
- (2014) Gian Maria Rossolini et al. CURRENT OPINION IN PHARMACOLOGY
- Era Of Faster FDA Drug Approval Has Also Seen Increased Black-Box Warnings And Market Withdrawals
- (2014) Cassie Frank et al. HEALTH AFFAIRS
- Repurposing the Antihistamine Terfenadine for Antimicrobial Activity against Staphylococcus aureus
- (2014) Jessamyn I. Perlmutter et al. JOURNAL OF MEDICINAL CHEMISTRY
- Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks
- (2014) Stephen M Strittmatter NATURE MEDICINE
- Phenotypic screening in cancer drug discovery — past, present and future
- (2014) John G. Moffat et al. NATURE REVIEWS DRUG DISCOVERY
- New FDA Breakthrough-Drug Category — Implications for Patients
- (2014) Jonathan J. Darrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Debate erupts on 'repurposed' drugs for Ebola
- (2014) M. Enserink SCIENCE
- Selective Chemical Inhibition of agr Quorum Sensing in Staphylococcus aureus Promotes Host Defense with Minimal Impact on Resistance
- (2014) Erin K. Sully et al. PLoS Pathogens
- Pharmaceutical R&D Performance by Firm Size
- (2013) Joseph A. DiMasi AMERICAN JOURNAL OF THERAPEUTICS
- Disruption of Biofilm Formation by the Human Pathogen Acinetobacter baumannii Using Engineered Quorum-Quenching Lactonases
- (2013) Jeng Yeong Chow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Is the GAIN Act a turning point in new antibiotic discovery?
- (2013) Eric D. Brown CANADIAN JOURNAL OF MICROBIOLOGY
- Innovating by Developing New Uses of Already-Approved Drugs: Trends in the Marketing Approval of Supplemental Indications
- (2013) Joseph A. DiMasi CLINICAL THERAPEUTICS
- Shifting from the single to the multitarget paradigm in drug discovery
- (2013) José L. Medina-Franco et al. DRUG DISCOVERY TODAY
- Phenotypic screens as a renewed approach for drug discovery
- (2013) Wei Zheng et al. DRUG DISCOVERY TODAY
- Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines
- (2013) Guangxu Jin et al. DRUG DISCOVERY TODAY
- Prospects for new antibiotics: a molecule-centered perspective
- (2013) Christopher T Walsh et al. JOURNAL OF ANTIBIOTICS
- A comprehensive regulatory framework to address the unmet need for new antibacterial treatments
- (2013) John H Rex et al. LANCET INFECTIOUS DISEASES
- Platforms for antibiotic discovery
- (2013) Kim Lewis NATURE REVIEWS DRUG DISCOVERY
- Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae
- (2013) Kimberly M. Carlson-Banning et al. PLoS One
- Challenges and opportunities of drug repositioning
- (2013) Natalia Novac TRENDS IN PHARMACOLOGICAL SCIENCES
- Antibiotic adjuvants: identification and clinical use
- (2013) Patricia Bernal et al. Microbial Biotechnology
- A Whole-Cell Phenotypic Screening Platform for Identifying Methylerythritol Phosphate Pathway-Selective Inhibitors as Novel Antibacterial Agents
- (2012) Charles A. Testa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Orphan Drugs for Rare Diseases
- (2012) Steven Simoens et al. DRUGS
- NCATS launches drug repurposing program
- (2012) Malorye Allison NATURE BIOTECHNOLOGY
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Penicillin: the medicine with the greatest impact on therapeutic outcomes
- (2011) Nelson Kardos et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Drug repositioning for orphan diseases
- (2011) D. Sardana et al. BRIEFINGS IN BIOINFORMATICS
- Challenges of Antibacterial Discovery
- (2011) L. L. Silver CLINICAL MICROBIOLOGY REVIEWS
- Resistance drives antibacterial drug development
- (2011) Ursula Theuretzbacher CURRENT OPINION IN PHARMACOLOGY
- Retrospective clinical analysis for drug rescue: for new indications or stratified patient groups
- (2011) David Cavalla et al. DRUG DISCOVERY TODAY
- Antibiotic adjuvants: multicomponent anti-infective strategies
- (2011) Lindsay Kalan et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Discovery research: the scientific challenge of finding new antibiotics
- (2011) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Drug repositioning: Re-investigating existing drugs for new therapeutic indications
- (2011) BM Padhy et al. Journal of Postgraduate Medicine
- Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
- (2011) Linda Ejim et al. Nature Chemical Biology
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- Use of Ichip for High-Throughput In Situ Cultivation of "Uncultivable" Microbial Species
- (2010) D. Nichols et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future
- (2010) K. Mazumdar et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The continuing crisis in antibiotic resistance
- (2010) G.L. French INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
- (2009) Samuel Broder ANTIVIRAL RESEARCH
- Antibiotics for Emerging Pathogens
- (2009) M. A. Fischbach et al. SCIENCE
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide
- (2008) I. Couto et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
- (2008) Rosemarie O’Shea et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started